Navigation Links
Pharmacyclics Reports Recent Developments and Financial Results for Fiscal Second Quarter 2011
Date:2/4/2011

GAAP net loss$
(6,147)$
(1,407)Non-GAAP net loss per share$
(0.10)$
(0.03)(1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our financial statements prepared in accordance with GAAP.

(2) All share-based compensation was excluded for the non-GAAP analysis.

(3) Represents a reclaiming of paid French Withholding Tax of $550 thousand for the $11 million upfront payment from Servier.

(4) Represents the therapeutic discovery project tax grant, net of related expenses.

(5) Represents the pro-rata portion of services performed under the Servier Collaboration arrangement prior to fiscal year 2010.Reconciliation of Selected GAAP Measures to Non-GAAP Measures (1)(unaudited; in thousands, except per share data)Six Months EndedDecember 31,20102009GAAP net loss$
(15,022)$
(5,063)Adjustments:Research & development share-based compensation(2)

2,961374General & administrative share-based compensation(2)

1,149446Interest adjustment for related party loan(3)

-21Income tax adjustment(4)

-(550)Therapeutic discovery project tax grant, net(5)

(586)-3,524291License and collaboration revenues(6)

-(1,211)-(1,211)Non-GAAP net loss$
(11,498)$
(5,983)Non-GAAP net loss per share$
(0.19)$
(0.13)(1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our financial statements prepared in accordance with GAAP.(2) All share-based compensation was excluded for the non-GAAP analysis.(3) Due to the below market interest rate of the related party loan, total GAAP interest expense includes non-cash interest expense of $21 for the six months ended December 31, 2009.(4) Represents a recla
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Pharmacyclics Announces Date of Fourth Quarter and Fiscal Year End 2009 Conference Call
2. Pharmacyclics to Present and Webcast at Upcoming Life Sciences Investor Conferences
3. Pharmacyclics, Inc. Rights Offering Oversubscribed
4. Pharmacyclics Announces Subscription Price for Rights Offering
5. Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference
6. Pharmacyclics Files Registration Statement for Rights Offering
7. Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results
8. Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth
9. Pharmacyclics Secures $5.0 Million in Debt Financing
10. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
11. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... The Remedy Group , the ... the specialty pharmacy industry, will be exhibiting, presenting, and ... Pharmacy Summit. The Summit will be held May 4-8, ... is the largest annual gathering for the specialty pharmacy ... pharmacy providers, pharma/biotech manufacturers, and payers, to learn more ...
(Date:5/5/2015)... RURO, Inc., a leading LIMS, RFID and ... latest major content upgrade to its bestselling, Commercial Off-The-Shelf ... is a significant advancement of FreezerPro® system , ... while also simplifying , New FreezerPro® ... Download available immediately for free to “Gold” support ...
(Date:5/5/2015)... May 5, 2015  Blueprint Medicines (NASDAQ: ... initial public offering of 9,367,708 shares of common ... per share, including shares of common stock issued ... their option to purchase additional shares. The gross ... Medicines were approximately $168.6 million, before underwriting discounts and ...
(Date:5/5/2015)... May 5, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, ... results for the three months ended March 31, 2015 ... amounts are in Canadian dollars. Effective ... end from May 31 to December 31. As a ... reported is for the three months ended March 31, ...
Breaking Biology Technology:The Remedy Group presenting at the 2015 Armada Specialty Pharmacy Summit: The Pitfalls to Growth and Maintaining the Patient Experience 2RURO Releases version 7 of FreezerPro® software 2Blueprint Medicines Announces Closing of Initial Public Offering 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 3Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 4Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 5Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 6Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 7Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 8
... Precision Farming Technology Available to Industry and Pioneer Customers , ... ... 2008 -- DuPont business Pioneer Hi-Bred and MapShots today ... a privately owned agricultural data management company that develops and sells ...
... one of the nation,s largest non-profit providers of skin, ... procedures, will this year sponsor one of the 26 ... the January 1 Tournament of Roses Parade(R). The float, ... the millions of people touched by organ, tissue and ...
... Dec. 26 Interleukin Genetics, Inc. (NYSE Alternext US: ... Company received notice from the NYSE Alternext US LLC ... in compliance with certain conditions of the Exchange,s continued ... Specifically, the Exchange noted the Company,s failure to comply ...
Cached Biology Technology:DuPont Acquires Ag Data Management Business to Enhance Information Solutions for Growers 2DuPont Acquires Ag Data Management Business to Enhance Information Solutions for Growers 3AlloSource, Tissue Recipient Join 'Stars of Life' Affected by Organ and Tissue Donation Aboard Donate Life Float in 2009 Rose Parade(R) 2AlloSource, Tissue Recipient Join 'Stars of Life' Affected by Organ and Tissue Donation Aboard Donate Life Float in 2009 Rose Parade(R) 3Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii) 2Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii) 3
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/27/2015)...  For more than four decades, AUVSI,s Unmanned ... premier worldwide event for the unmanned land, sea, and ... for any local, national, or trade news organization interested ... and current applications of unmanned technologies. The conference will ... billion industry, and how it will soon impact the ...
(Date:4/27/2015)... Conn. , Apr. 27, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... commence shipping to pre-order customers the first week of ... through the month of May. ... a significant milestone for the company as Wocket® enters ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
... June 30, 2011 , the New York Academy ... jointly hosting "Innovating on a Shoestring ," a ... deploy appropriate and necessary technologies for patients and physicians ... led by Dr. Jacqueline Linnes of D-Lab, a world-famous ...
... made its mark large and small in innumerable ... has evolved too. Researchers looked at muscles that control ... in mammals. They learned that fish use tongue muscles primarily ... as if the morsel were an object in an assembly ...
... Research Laboratory Bioenergy and Biofabrication Section in the ... the Acoustic Division, the Zero Power Ballast Control ... energy harvesting developments to enable unsupervised underwater sensing ... an ultimate goal of producing simple, small, power-efficient ...
Cached Biology News:New York Academy of Science to host a workshop on innovating for the developing world 2Tongue makes the difference in how fish and mammals chew 2Tongue makes the difference in how fish and mammals chew 3Navy, Marine Corps tests autonomous zero-power bathythermograph sensors 2
... S&S Custom Array Service enables scientists who have ... to have FAST Slides printed with proteins from ... Processing of the arrays is performed by the ... S&S to discuss your needs with an expert ...
... The high-performance triple quadrupole 1200L sets ... today's cost-conscious environment - incorporating the ... for all liquid chromatography analytical needs. ... interface and the Transmission Quadrupole Analyzer ...
... Do you need to make your strain ... efficiency? Take advantage of Lucigen’s unrivalled expertise ... Competent Cell Service offers: Chemically ... efficiencies Fast turnaround ...
Glucagon-like peptide-1 (GLP-1 (1-36) amide)...
Biology Products: